Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to 244.13%.

  • Celularity's EBIT Margin fell 1201300.0% to 244.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 209.78%, marking a year-over-year decrease of 1770700.0%. This contributed to the annual value of 70.75% for FY2024, which is 7736900.0% up from last year.
  • As of Q3 2025, Celularity's EBIT Margin stood at 244.13%, which was down 1201300.0% from 276.57% recorded in Q2 2025.
  • Over the past 5 years, Celularity's EBIT Margin peaked at 423.47% during Q4 2022, and registered a low of 2621.66% during Q3 2023.
  • Over the past 5 years, Celularity's median EBIT Margin value was 244.13% (recorded in 2025), while the average stood at 624.95%.
  • Its EBIT Margin has fluctuated over the past 5 years, first tumbled by -24851200bps in 2023, then soared by 24976600bps in 2024.
  • Celularity's EBIT Margin (Quarter) stood at 307.89% in 2021, then skyrocketed by 238bps to 423.47% in 2022, then tumbled by -74bps to 109.93% in 2023, then crashed by -1327bps to 1348.84% in 2024, then skyrocketed by 82bps to 244.13% in 2025.
  • Its EBIT Margin stands at 244.13% for Q3 2025, versus 276.57% for Q2 2025 and 91.77% for Q1 2025.